CD9 and breast carcinoma: In addition, negative MRP-1/CD9 expression was associated with a poor prognosis in breast cancer (Miyake et al, 1996), lung cancer (Higashiyama et al, 1995) and pancreatic cancer (Sho et al, 1998).